IRIS
VENA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.775
AS - Asia 132
SA - Sud America 43
NA - Nord America 14
AF - Africa 1
Totale 10.965
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 10.771
CN - Cina 90
BR - Brasile 31
VN - Vietnam 22
SG - Singapore 17
US - Stati Uniti d'America 13
AR - Argentina 4
EC - Ecuador 4
PY - Paraguay 2
AT - Austria 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
FR - Francia 1
GB - Regno Unito 1
HK - Hong Kong 1
ID - Indonesia 1
IQ - Iraq 1
RU - Federazione Russa 1
TN - Tunisia 1
Totale 10.965
Salva come PNG Salva come JPEG
Città #
Genoa 5.931
Genova 2.105
Vado Ligure 1.451
Rapallo 1.199
Bordighera 77
Beijing 44
Ashburn 12
Singapore 8
Ho Chi Minh City 7
Hanoi 5
Porto Alegre 3
Milan 2
Quito 2
Rome 2
Treviglio 2
Verona 2
Anápolis 1
Baghdad 1
Bagé 1
Barra do Piraí 1
Betim 1
Biên Hòa 1
Boydton 1
Brasília 1
Bạc Liêu 1
Cabo Frio 1
Carapicuíba 1
Curitiba 1
Divinópolis 1
Freyre 1
Guararema 1
Guayaquil 1
Ha Long 1
Haiphong 1
Hong Kong 1
Hải Dương 1
Ijuí 1
Ilhéus 1
Indramayu 1
Ipojuca 1
Itaquaquecetuba 1
Katueté 1
Londrina 1
Luque 1
Mar del Plata 1
Ninh Bình 1
Oriximiná Municipality 1
Pelotas 1
Quận Chín 1
Reconquista 1
Resende 1
Rio de Janeiro 1
Salvador 1
Santiago 1
Sousa 1
São Paulo 1
Teresina 1
Thái Bình 1
Thái Nguyên 1
Tiền Giang 1
Tunis 1
Tuparendi 1
Uberlândia 1
Valença 1
Viamão 1
Vienna 1
Volgograd 1
Worcester 1
Totale 10.904
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 262
Mould Infections of Traumatic Wounds: A Brief Narrative Review 203
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 184
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 160
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 155
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 154
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review 153
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 152
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 149
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 147
Bloodstream infections in critically ill patients with COVID-19 142
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 135
Treatment of Infections Due to MDR Gram-Negative Bacteria 130
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 127
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 123
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic 123
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 117
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 117
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 116
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 113
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 111
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19 110
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective 107
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 100
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 97
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 97
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 91
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 91
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 91
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality 91
Characterization of T lymphocytes in severe COVID-19 patients 88
Antibiotic treatment of acute bacterial skin and skin structure infections 86
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 85
A comparative analysis of the first and second COVID-19 wave in Italy: evaluation of mortality in the Infectious Disease Unit of Genoa University Hospital 85
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 85
The role of new β-lactamase inhibitors in gram-negative infections 85
Diagnosis and Treatment of Candidemia in the Intensive Care Unit 84
Risk factors for candidemia after open-heart surgery: results from a multicenter case-control study 83
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 82
Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter Study 82
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 81
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 79
Early Effects of Passive Leg-Raising Test, Fluid Challenge, and Norepinephrine on Cerebral Autoregulation and Oxygenation in COVID-19 Critically Ill Patients 79
Adequate duration of therapy in severe fungal infections 79
Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients 78
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience 77
Antiviral treatment selection for SARS-CoV-2 pneumonia 76
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians? 76
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review 75
Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies 75
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 74
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 73
Towards the automatic calculation of the EQUAL Candida Score: Extraction of CVC-related information from EMRs of critically ill patients with candidemia in Intensive Care Units 73
Management of patients with septic shock due to Candida infection 72
Barriers to HCV micro-elimination in a cohort of people living with HIV (PLWH) 71
New antibiotics for ventilator-associated pneumonia 71
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales 71
Emerging treatment options for acute bacterial skin and skin structure infections: Focus on intravenous delafloxacin 71
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 70
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 70
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance 70
The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome 70
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring 70
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy 69
Isavuconazole shortens the QTc interval 69
Molecular epidemiological investigation of a nosocomial cluster of c. Auris: Evidence of recent emergence in italy and ease of transmission during the covid‐19 pandemic 68
Frequency of Detection of Candida auris Colonization Outside a Highly Endemic Setting: What Is the Optimal Strategy for Screening of Carriage? 68
How to manage Pseudomonas aeruginosa infections 67
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 66
Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant/ extensively drug-resistant/pandrug-resistant bacteria 65
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 64
The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm 64
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 63
Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19” 63
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia 63
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care 62
Rational approach in the management of Pseudomonas aeruginosa infections 62
Reuse of clinical COVID-19 patient data: Pre-processing for future classification 62
The multifaceted presentation of syphilitic chorioretinitis examined by multimodal imaging: A case series 61
Are incidence and epidemiology of anaerobic bacteremia really changing? 60
Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review 60
Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit 59
Antifungal stewardship in a tertiary-care institution: a bedside intervention 59
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience 58
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study 57
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 56
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 56
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 56
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 56
Treatment of severe infections due to metallo-β-lactamases-producing Gram-negative bacteria 56
An overview of micafungin as a treatment option for invasive candidiasis in pediatric patients younger than 4 months old 55
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria 54
Early versus late intubation in COVID-19 patients failing helmet CPAP: A quantitative computed tomography study 54
COVID-19: Some clinical questions after the first 4 months 53
Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2 52
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis 52
Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunction 51
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey (Infection, (2024), 52, 3, (1125-1141), 10.1007/s15010-023-02169-7) 51
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 50
Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence 49
Totale 8.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.136
article - articoli 60.136
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021516 0 0 0 0 40 41 80 67 73 98 70 47
2021/2022963 37 28 37 63 48 40 48 168 184 94 58 158
2022/20231.499 117 135 15 134 170 154 80 96 240 122 183 53
2023/20241.366 56 108 35 172 139 215 125 128 65 50 89 184
2024/20253.893 105 281 103 225 496 425 369 586 173 217 379 534
2025/20262.270 827 250 607 546 40 0 0 0 0 0 0 0
Totale 11.309